Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation

Summary:

To establish the most appropriate prophylactic therapy and risk factors for predicting hemorrhagic cystitis (HC) after stem cell transplantation (SCT), we retrospectively analyzed the clinical records of 450 transplant patients treated from 1982 to 2002. In all, 81 patients developed early- and/or late-onset HC (early=29, late=48, both=4). For the incidence of early-onset HC, administration of cyclophosphamide (CY) (p=0.0079, odds ratio (OD)=5.109, 95% confidence interval (CI)=1.533–17.030), busulfan (BU) (p=0.0015, OD=3.336, 95% CI=1.584–7.027), BU+CY (p=0.0001, OD=4.369, 95% CI=2.055–9.292), antithymocyte globulin (p=0.0009, OD=3.368, 95% CI=1.642–6.911), nonradiation (p=0.0163, OD=2.564, 95% CI=0.181–0.841), 2-mercaptoethane sodium sulfonate (Mesna) (p=0.0001, OD=7.519, 95% CI=2.847–19.858), and bladder irrigation (p=0.0001, OD=4.950, 95% CI=2.328–10.523) were risk factors. By Fisher's exact test, the combination of BU and Mesna was a more significant risk factor (P<0.001) than Mesna alone (p=0.008) compared to the administration of neither agent. By multivariate analysis, prophylactic administration of Mesna (p=0.0105, OD=5.301, 95% CI=1.477–19.026) and bladder irrigation (p=0.0001, OD=9.469, 95% CI=3.872–23.156) were significant risk factors of early-onset HC. We conclude that (i) high-dose BU as well as CY is a cause of HC, (ii) protective bladder irrigation has an opposite effect, and (iii) Mesna possibly has a toxic effect on bladder mucosa.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Russell SJ, Vowels MR, Vale T et al. Haemorrhagic cystitis in paediatric bone marrow transplant patients: an association with infective agents, GVHD and prior cyclophosphamide. Bone Marrow Transplant 1994; 13: 533–539.

    CAS  PubMed  Google Scholar 

  2. La Rosa AM, Champlin RE, Mirza N et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001; 32: 871–876.

    Article  CAS  PubMed  Google Scholar 

  3. Bedi A, Miller CB, Hanson JL et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13: 1103–1109.

    Article  CAS  PubMed  Google Scholar 

  4. Murphy GF, Wood Jr DP, McRoberts JW, Henslee-Downey PJ . Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin. J Urol 1993; 149: 565–566.

    Article  CAS  PubMed  Google Scholar 

  5. Arthur RR, Shah KV, Baust SJ et al. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986; 315: 230–234.

    Article  CAS  PubMed  Google Scholar 

  6. Ambinder RF, Burns W, Forman M et al. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation. Arch Intern Med 1986; 146: 1400–1401.

    Article  CAS  PubMed  Google Scholar 

  7. Shepherd JD, Pringle LE, Barnett MJ et al Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol 1991; 9: 2016–2020.

    Article  CAS  PubMed  Google Scholar 

  8. Cox PJ . Cyclophosphamide cystitis – identification of acrolein as the causative agent. Biochem Pharmacol 1979; 28: 2045–2049.

    Article  CAS  PubMed  Google Scholar 

  9. Hows JM, Mehta A, Ward L et al. Comparison of Mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study. Br J Cancer 1984; 50: 753–756.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Thomas AE, Patterson J, Prentice HG et al. Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy. Bone Marrow Transplant 1987; 4: 347–355.

    Google Scholar 

  11. Ost L, Lonnqvist B, Eriksson L et al. Hemorrhagic cystitis – a manifestation of graft versus host disease? Bone Marrow Transplant 1987; 1: 19–25.

    Google Scholar 

  12. Atkinson K, Biggs JC, Golovsky D et al. Bladder irrigation does not prevent haemorrhagic cystitis in bone marrow transplant recipients. Bone Marrow Transplant 1991; 7: 351–354.

    CAS  PubMed  Google Scholar 

  13. Brugieres L, Hartmann O, Travagli JP et al. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol 1989; 7: 194–199.

    Article  CAS  PubMed  Google Scholar 

  14. Sencer SF, Haake RJ, Weisdorf DJ . Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications. Transplantation 1993; 56: 875–879.

    Article  CAS  PubMed  Google Scholar 

  15. Seber A, Shu XO, Defor T et al. Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 1999; 23: 35–40.

    Article  CAS  PubMed  Google Scholar 

  16. Morgan M, Dodds A, Atkinson K et al. The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation. Br J Haematol 1991; 77: 529–534.

    Article  CAS  PubMed  Google Scholar 

  17. Ringden O, Labopin M, Tura S et al. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 1996; 93: 637–645.

    Article  CAS  PubMed  Google Scholar 

  18. Vose JM, Reed EC, Pippert GC et al. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol 1993; 11: 1306–1310.

    Article  CAS  PubMed  Google Scholar 

  19. Moriyama Y, Koike T, Shibata A . Hemorrhagic cystitis after conditioning for bone marrow transplantation and its prophylaxis. Jpn J Clin Oncol 1984; 14: 531–536.

    PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to Mr Hiroki Akiyama (Meiji Seika Kaisha, Ltd) for performing the statistical analysis of the data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K Kishi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsuboi, K., Kishi, K., Ohmachi, K. et al. Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 32, 903–907 (2003). https://doi.org/10.1038/sj.bmt.1704240

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704240

Keywords

This article is cited by

Search

Quick links